Vivani Medical
VANI
57 hedge funds and large institutions have $13M invested in Vivani Medical in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 13 closing their positions.
70% more call options, than puts
Call options by funds: $1M | Put options by funds: $592K
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
8% less funds holding
Funds holding: 62 → 57 (-5)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
34% less capital invested
Capital invested by funds: $19.9M → $13M (-$6.84M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
+$1.62M |
| 2 |
State Street
Boston,
Massachusetts
|
+$365K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$280K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$179K |
| 5 |
Goldman Sachs
New York
|
+$167K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZCA
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
-$2.92M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$836K |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$732K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$625K |
| 5 |
Millennium Management
New York
|
-$546K |
VANI Hedge Fund Activity: Q1 2016 in Review
57 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2016, worth a combined $13M — down 34% from $19.9M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of VANI and 9 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 17 added.
The largest buyer was Harvest Capital Strategies, adding an estimated $1.62M. The largest seller was Zeke Capital Advisors, exiting entirely with an estimated $2.92M sold.
- 57 institutional investors held Vivani Medical (VANI) as of Q1 2016, down from 62 in Q4 2015.
- Funds reported $13M of Vivani Medical stock for Q1 2016, down 34% quarter-over-quarter.
- 9 funds opened new Vivani Medical positions in Q1 2016 and 13 closed out, a net change of -4 holders.
- The largest Vivani Medical buyer in Q1 2016 was Harvest Capital Strategies, an estimated $1.62M added.
- The largest Vivani Medical seller in Q1 2016 was Zeke Capital Advisors, an estimated $2.92M sold.
Based on aggregated 13F filings for Q1 2016.